Publications found:
73,128
Sort by:
Tuberculosis Therapeutics: Market Research Report
US$ 3,450.00
This report analyzes the Global market for Tuberculosis Therapeutics in US$ Million. Annual estimates and forecasts are provided for the period 2006 ... SA, Summit Plc, Tibotec BVBA, Otsuka Pharmaceutical Co., Ltd., and Sequella, Inc. Market data and analytics are derived from primary and secondary research. ...
April 2010
366 pages
Multiple Sclerosis Therapeutics: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Multiple Sclerosis Therapeutics in US$ Billion. The report provides separate comprehensive analytics for the US, Japan, Europe and Rest of World. Annual estimates and forecasts are provided for each region for the period 2006 through 2015. The report profiles ...
April 2010
430 pages
Melanoma Therapeutics: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Melanoma Therapeutics in US$ Million. The report provides separate comprehensive analytics for US, and Rest of ... through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 73 companies including many key and niche players ...
April 2010
615 pages
Dyslipidemia Therapeutics: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Dyslipidemia Therapeutics in US$ Million by the following segments - Statins, and Non-Statins. The report provides ... Mylan, Inc., Novartis AG, Pfizer, Inc., and Teva Pharmaceutical Industries Ltd. Market data and analytics are derived from primary and secondary ...
April 2010
429 pages
Lymphoma Therapeutics: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Lymphoma Therapeutics in US$ Million. The report provides separate comprehensive analytics for US, Europe, and ... ., ImmunoGen, Inc., InNexus Biotechnology, Inc., and Millennium Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary ...
April 2010
752 pages
The AstraZeneca Intelligence Dossier
US$ 295.00
One step forward, two steps back. At least that’s what the last two quarters of 2009 seemed like for pharmaceutical giant, AstraZeneca. Despite a strong showing in news analysis — of 221 articles publ...
March 2010
69 pages
The Johnson & Johnson Intelligence Dossier
US$ 295.00
May you live in interesting times—or so the old curse goes. Johnson & Johnson is certainly doing just that. After a year of upsets and some victories, J&J ended the last half of 2009 with the...
March 2010
35 pages
The Bristol-Myers Squibb Intelligence Dossier
US$ 295.00
“Without the strength to endure the crisis, one will not see the opportunity within,” author and business commentator Chin-Ning Chu recently said. “It is within the process of endurance that opportuni...
March 2010
51 pages
The Eli Lilly Intelligence Dossier
US$ 295.00
From the ashes of recent economic fires, a new leader is rising. Following one of the worst years ever for the pharmaceutical industry, in which economic downturn was compounded by regulatory crises,...
March 2010
46 pages
Engaging with Physicians in an Era of Transparency
US$ 595.00
“It's no use going back to yesterday,” Alice said in Wonderland, “because I was a different person then.”As Alice’s environment changed her, so, too, is an era of “looking glass” transparency changing...
March 2010
51 pages
Competitor Analysis: Biologic and Immune Therapy of S. aureus Infections
US$ 230.00
... a hyperlink leading to the source of information. Index Proteins & peptides Antibodies Vaccines Corporate R&D Pipelines of Biologic and Immuno Therapeutics of S. aureus infections About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS, but concise ...
March 2010
28 pages
Global Probiotics Market: Trends and Opportunities
US$ 800.00
... humans. The present report offers an analysis of the global probiotics market and assesses the market by geography and also by segments. It analyzes the ... to be leveraged. It also discusses the major market trends and challenges faced by the Probiotics market. The report also presents the competitive structure ...
February 2010
40 pages
Hearing Aid Market Report: 2010 Edition
US$ 800.00
... . The report offers an analysis of the worldwide hearing aid industry with a special focus on the US market. It also discusses major market trends and ... growth drivers. The report gives an ...
February 2010
35 pages
Brief Report: Interleukin-17 (IL-17R) and IL-17 Receptor Antagonists
US$ 575.00
Product description The present Brief Report about molecules targeting interleukin-17 (IL-17) or its receptor provides an assessment, competitor evaluation and detailed profiles of antibodies and other molecules in development. R&D projects of primarily antibodies targeting IL-17 or IL-17R to treat ...
February 2010
42 pages
Competitor Analysis: BlyS, BAFF & APRIL Antagonists
US$ 115.00
... leading to the source of information. Index BlyS, BAFF & APRIL Targeted Therapy Corporate BlyS, BAFF & APRIL R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS , but concise information about the pipeline of R&D projects for targets, ...
February 2010
12 pages
Competitor Analysis: Notch Pathway Inhibitors
US$ 115.00
... , R&D Stage and additional comments with a hyperlink leading to the source of information. Index Notch Pathway Inhibitors Corporate Notch Pathway Inhibitor R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS , but concise ...
February 2010
10 pages
Oncology Pipeline Database: 6-Month Subscription
US$ 1,380.00
Product description Subscription to La Merie's proprietary Oncology Pipeline Database provides online access to more than 3,000 project entries in oncology. Each project is specified for its Target or Mechanism of Action, Product Category and R&D Phase. Use of the R&D database of cancer drugs is intuitive ...
February 2010
-
Advanced Wound Care Products: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Advanced Wound Care Products in US$ Million by the following product segments: Moist Dressings, Antimicrobial Dressings ... through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 51 companies including many key and niche ...
February 2010
341 pages
Rheumatoid Arthritis Therapeutics: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Rheumatoid Arthritis Therapeutics in US$ Million.The report provides separate comprehensive analytics for US, Japan, ... Johnson & Johnson Services, Inc., Schering-Plough Corp., UCB S.A., and Wyeth. Market data and analytics are derived from primary and secondary ...
February 2010
824 pages
Anti-Infectives: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Anti-Infectives in US$ Million. The report provides separate comprehensive analytics for US, Japan, Europe, ... Inc., Novartis AG, Pfizer, Inc., Sanofi-Aventis SA, and Wyeth Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary ...
February 2010
825 pages
KOL Management - The New Rules
US$ 395.00
“When the going gets tough,” Joseph P. Kennedy once said, “the tough get going…” And when it comes to the beleaguered pharmaceutical industry, he could have added, “… then they rethink how they do bus...
January 2010
33 pages
The CME Landscape - Change and Challenges
US$ 395.00
“The future influences the present just as much as the past.” ~ (Friedrich Nietzsche, scholar and philosopher)When it comes to the past, present and future of the continuing medical education (CME) in...
January 2010
36 pages
Analysis of Telemedicine Market
US$ 800.00
... rate and increasing health expenditure in emerging economies. However, the telemedicine market is also facing challenges like reimbursement by third party payers, ... the major market players with a discussion of their key business strategies. By combining SPSS Inc.’s data integration and analysis capabilities ...
January 2010
40 pages
Home Healthcare Market (2009-2014)
US$ 3,390.00
... years. Market Estimates and Forecast The report provides in-depth market estimates and forecasts for the global home healthcare market as follows: • Home Healthcare Equipment - Home therapeutic equipment (oxygen delivery systems, CPAP, nebulizers, ventilators, humidifiers, IV diagnostics, home dialysis, ostomy supplies, and others) - Home ...
January 2010
300 pages
Global Dental Consumables Market
US$ 3,390.00
... dental hand pieces, dental preventives, endodontics, and infection control products. This report provides an extensive analysis of the global dental consumables market, including current market size, market forecasts, market trend analysis, as well as a competitive analysis of the recent developments in the dental consumables market. The report also ...
January 2010
195 pages
Competitor Analysis: PSMA & PSA Targeted Therapy
US$ 172.50
... targeted therapy of prostate and other cancers. Prostate-specific antigen (PSA) was discovered more than 20 years ago and has become the ... PSA Targeted Therapy Corporate PSMA & PSA Targeted Therapy R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers ...
January 2010
18 pages
Competitor Analysis: Selective Estrogen Receptor Modulators
US$ 172.50
... Indication, R&D Stage and additional comments with a hyperlink leading to the source of information. Index Selective Estrogen Receptor Modulators Corporate SERM R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS , but concise ...
January 2010
19 pages
Global Dental Industry: An Analysis
US$ 800.00
... have also impacted the growth of the industry positively. The main driving element for global dental equipment market is the advancement in technologies ... with 20% of market share. The report focuses on various aspects of dental industry including the market size and geographical segmentation of the market ...
December 2009
41 pages
Competitor Analysis: Neurotrophic Growth Factors
US$ 460.00
... disease Alzheimer's disease Multiple sclerosis Huntington's disease Ophthalmic diseases Various Corporate Neurotrophic Growth Factor R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS , but concise information about the pipeline of ...
December 2009
38 pages
Competitor Analysis: Growth Factors for Bone, Dental, Cartilage and Tendon Repair
US$ 345.00
... engineered peptides, antibodies, small molecules or even plasmids. Among the growth stimulators are the BMPs, GDFs, PDGF, PTH receptor agonists, ... , Dental, Cartilage and Tendon Growth Factor R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS ...
December 2009
42 pages
Competitor Analysis: Tissue Growth Factors
US$ 920.00
... description The present Competitive Intelligence Report about tissue growth factors provides a competitor evaluation in the field of molecules such as proteins, peptides ... as HGF, VEGF, TGF, NGF, GDF and quite a number of neurotrophic factors are under development. Apart from proteins as the classical drugs ...
December 2009
57 pages
Competitor Analysis: FGF-R Agonists and Antagonists
US$ 207.00
Product description The present Competitive Intelligence Report about TGF-R agonists and antagonists provides a competitor evaluation in the field of transforming growth factor receptor (TGF-R) or TG...
November 2009
20 pages
The Roche Intelligence Dossier
US$ 295.00
As the fourth largest pharmaceutical company in the world, with annual revenues of $43.9 billion, some of the most instantly recognisable drugs marketed and the kind of pipeline smaller companies only...
November 2009
48 pages
The GSK Intelligence Dossier
US$ 295.00
After two anemic years, GSK is ready to breathe new life.Despite intense competition from generics in the US, the company has finally reported a healthy growth in the third quarter of 2009.Now, eager...
November 2009
53 pages
The Novartis Intelligence Dossier
US$ 295.00
International censure over Novartis’ grave delays in supplying the H1N1 vaccine.Renewed criticism by an institutional investor for CEO Daniel Vasella’s substantial pay package and considerable power.A...
November 2009
55 pages
Opportunity Analysis of H1N1 (swine flu) Vaccination Market
US$ 3,390.00
... and forecast This report will enable strategic understanding and opportunities in the H1N1 2009 influenza vaccines market. The report covers the ... positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders. - Comprehensive market analysis for the following sectors: ...
November 2009
126 pages
Competitor Analysis: FGF-R Agonists and Antagonists
US$ 345.00
Product description The present Competitive Intelligence Report about FGF-R agonists and antagonists provides a competitor evaluation in the field of fibroblast growth factor receptor (FGF-R) or PDGF targeting molecules for wound healing, cardiac tissue repair, bone formation or treatment of cancer as of ...
November 2009
37 pages
Competitor Analysis: Proteasome Inhibitors
US$ 115.00
... R&D Stage and additional comments with a hyperlink leading to the source of information. Index Velcade Pipeline Proteasome Inhibitors Corporate Proteasome Inhibitor R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS , but concise ...
November 2009
14 pages
Competitor Analysis: CXCR and CXCL Agonists and Antagonists
US$ 345.00
... The present Competitive Intelligence Report about CXCR agonists and CXCR/CXCL antagonists provides a competitor evaluation in the field of chemokine receptor ... approved and marketed drug is plerixafor (AMD3100), a small molecule inhibitor of the CXCR-4/SDF-1 axis, used for stem cell mobilization. CXCR1 and ...
November 2009
30 pages
Conference Intelligence Dossier: EASD Annual Meeting 2009
US$ 995.00
The numbers are staggering: More than 200 million people around the world now suffer from diabetes and its major complications. According to the World Health Organization, that figure is expected to s...
October 2009
90 pages
The Pfizer Intelligence Dossier
US$ 295.00
In boardrooms, around water coolers and behind closed office doors, decision-makers in the pharmaceutical industry are asking questions: What’s happening with Pfizer? What developments have occurred i...
October 2009
60 pages
Autoimmune Treatment (2009 - 2014)
US$ 3,390.00
... . The global market for autoimmune disease treatments is estimated to be at $37.84 billion in 2009, and is growing at a CAGR of 12.7% from 2009 to 2014 to reach an estimated $68.81 billion in 2014. The effects of the global ... 2009 to 2014. Scope of the Report The report provides market overviews and forecasts as well as market drivers and restraints for the global autoimmune treatment ...
September 2009
159 pages
